CSI Market
Sign In | Register

Orchestra Biomed Holdings Inc (OBIO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OBIO Annual Cash Flow →
The table below presents a historical view of Orchestra Biomed Holdings Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-89.18
Depreciation & amortization0.19
Amortization of Other Assets0.13
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.06
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation5.65
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Operating Lease Right Of Use Asset Amortization Expense0.16
Increase Decrease In Operating Lease Liability-0.17
Non Cash Interest Expense On Liability Related To Revenue Interest Purchase Agreement1.31
Income taxes0.00
Gain (Loss) on Sale of Investments2.29
Increase (Decrease) in Accounts Receivable-0.04
Increase (Decrease) in Accounts Payable and Accrued Liabilities-3.31
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.48
Payments for (Proceeds from) Other Operating Activities42.39
Discontinued operations0.00
Net Cash flow from Operating Activities-41.50
Investing Activities
Capital Expenditures-0.44
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities38.79
Payments to Acquire Marketable Securities-56.13
Real Estate Investments0.00
Payments For Strategic Investments-
Payments To Acquire Assets Of Business-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Long-term Investments4.78
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-5.86
Discontinued operations0.00
Net Cash Flow from Investing Activities-12.99
Financing Activities
Short-term debt Net20.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.03
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.62
Other net20.86
Other General Expense-
Redemption Of Public Share-
Deferred Financing Offering And Merger Costs-
Sale Of Stock Consideration Received On Transaction5.86
Deferred Financing Costs-
Proceeds From Sale Of Common Stock And Warrants Net Of Issuance Costs-
Proceeds From Revenue Interest Purchase Agreement-
Payments For Revenue Interest Purchase Agreement-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities40.27
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-41.94
Total Cash Flow-14.22
4 historic quarters locked

Sign in to unlock the full Orchestra Biomed Holdings Inc cash flow history.

Sign In Create Free Account

About Orchestra Biomed Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-093357

Figures are derived from filed reports and may be restated. Historical data is subject to revision.